Free Trial

Pictet Asset Management Holding SA Has $10.66 Million Holdings in DocuSign, Inc. (NASDAQ:DOCU)

DocuSign logo with Computer and Technology background
Remove Ads

Pictet Asset Management Holding SA boosted its holdings in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 41.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 118,551 shares of the company's stock after acquiring an additional 34,688 shares during the quarter. Pictet Asset Management Holding SA owned about 0.06% of DocuSign worth $10,662,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of DOCU. Itau Unibanco Holding S.A. acquired a new stake in shares of DocuSign during the third quarter worth $28,000. Kestra Investment Management LLC purchased a new position in DocuSign in the 4th quarter worth about $30,000. Modus Advisors LLC acquired a new stake in DocuSign during the 4th quarter worth about $36,000. First Horizon Advisors Inc. lifted its stake in DocuSign by 102.6% during the fourth quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock valued at $36,000 after buying an additional 201 shares in the last quarter. Finally, Avion Wealth boosted its holdings in shares of DocuSign by 309.2% in the fourth quarter. Avion Wealth now owns 487 shares of the company's stock worth $43,000 after buying an additional 368 shares during the period. 77.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

DOCU has been the subject of several research analyst reports. Wedbush restated a "neutral" rating and issued a $100.00 price target on shares of DocuSign in a research report on Friday, March 14th. Citigroup raised their target price on DocuSign from $113.00 to $115.00 and gave the stock a "buy" rating in a research report on Friday, March 14th. Morgan Stanley upped their price target on DocuSign from $62.00 to $97.00 and gave the company an "equal weight" rating in a research report on Friday, December 6th. Royal Bank of Canada restated a "sector perform" rating and set a $90.00 price objective on shares of DocuSign in a research report on Friday, March 14th. Finally, Robert W. Baird set a $93.00 target price on DocuSign in a report on Friday, March 14th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $95.83.

Remove Ads

Get Our Latest Research Report on DOCU

DocuSign Stock Performance

Shares of DocuSign stock traded down $5.16 during midday trading on Friday, reaching $72.21. 2,881,620 shares of the company's stock traded hands, compared to its average volume of 2,695,162. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The company's 50 day simple moving average is $86.02 and its 200 day simple moving average is $81.98. The company has a market cap of $14.62 billion, a price-to-earnings ratio of 14.89, a price-to-earnings-growth ratio of 6.94 and a beta of 1.20.

DocuSign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.02. The company had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business's revenue was up 9.0% compared to the same quarter last year. During the same period last year, the company earned $0.76 earnings per share. As a group, equities research analysts predict that DocuSign, Inc. will post 1.17 earnings per share for the current year.

Insider Buying and Selling at DocuSign

In other DocuSign news, insider James P. Shaughnessy sold 7,500 shares of the company's stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total transaction of $609,825.00. Following the completion of the sale, the insider now directly owns 45,875 shares in the company, valued at $3,730,096.25. This represents a 14.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Peter Solvik sold 10,000 shares of DocuSign stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $91.26, for a total value of $912,600.00. Following the completion of the transaction, the director now owns 150,253 shares in the company, valued at $13,712,088.78. The trade was a 6.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 57,851 shares of company stock worth $4,911,319 over the last 90 days. Insiders own 1.66% of the company's stock.

About DocuSign

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Recommended Stories

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads